ArticleFrontiers in surgery2025
Nursing strategies after pancreaticoduodenectomy: continuity of care combined with immunomodulatory nutrition.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreaticoduodenectomy (PD) is a highly invasive procedure with a long operation time, resulting in a high incidence of postoperative complications. The quality of patient care remains a key factor in improving prognosis. This study aimed to evaluate the impact of continuity of care combined with immunomodulatory nutrition on the postoperative recovery and quality of life of patients undergoing PD surgery. Methods: This was a randomized controlled study involving 120 patients who underwent PD surgery at our hospital between February 2022 and February 2024. The patients were randomly divided into the conventional care group (CG) and the intervention group (IG), with the latter receiving continuity of care combined with arginine-rich immunonutritional support. The main observation indicators included survival analysis, recovery of gastrointestinal function, length of hospital stay, nutritional status, immune function, postoperative complications, negative emotions and quality of life. Results: There was no significant difference in the overall survival rate between the two groups. Compared with the CG, the IG had shorter length of hospital stay, better recovery of gastrointestinal function, better improvements of nutritional indicators such as ALB and PAB, lower levels of pro-inflammatory factors TNF-α, IL-6 and CRP, better improvement of CD4 Conclusion: Continuity of care combined with immunomodulatory nutrition provides a strong rationale for postoperative care of PD, and is worthy of clinical promotion and practice. More clinical cases and long-term follow-ups are needed to further verify its effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.